Glaukos Corp. | Mutual Funds
Mutual Funds that own Glaukos Corp.
American Funds Small Cap World Fund
2,792,481
7.92%
52,481
0.5%
06/30/2018
Janus Triton Fund
1,604,348
4.55%
0
0.94%
06/30/2018
T Rowe Price New Horizons Fund
1,079,385
3.06%
1,079,385
0.3%
06/30/2018
Janus Global Life Sciences Fund
1,005,937
2.85%
-62,643
1.69%
06/30/2018
Vanguard Small Cap Index Fund
790,671
2.24%
11,027
0.06%
07/31/2018
Vanguard Total Stock Market Index Fund
787,804
2.24%
0
0.01%
07/31/2018
Ivy Mid Cap Growth Fund
755,033
2.14%
300,755
1.09%
06/30/2018
iShares Russell 2000 ETF
690,957
1.96%
-369
0.1%
09/06/2018
William Blair Small Mid Cap Growth Fund
642,198
1.82%
24,800
1.63%
06/30/2018
Janus Contrarian Fund
626,548
1.78%
-102,142
1.54%
06/30/2018
| Address |
229 Avenida Fabricante
San Clemente California 92672
United States
|
|
Employees
|
- |
| Website |
http://www.glaukos.com |
| Updated |
07/08/2019 |
| Glaukos Corp. is an ophthalmic medical device company, which engages in the development and commercialization of surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Its Micro Invasive Glaucoma Surgery procedures are designed to reduce intraocular eye pressure by improving aqueous outflow through the natural physiologic pathway. The company was founded by Olav B. |
